MedPath

Impact of pre-transplantation minimal residual disease (MRD) on the ...

Study on 114 acute leukemia patients undergoing allo-HSCT found MRD+ status pre-transplant linked to worse survival outcomes. MRD+ group had higher relapse rates and significantly lower one-year OS and PFS. MRD+ is an independent risk factor for OS, suggesting need for better chemo regimens and GvHD management.


Reference News

Impact of pre-transplantation minimal residual disease (MRD) on the ...

Study on 114 acute leukemia patients undergoing allo-HSCT found MRD+ status pre-transplant linked to worse survival outcomes. MRD+ group had higher relapse rates and significantly lower one-year OS and PFS. MRD+ is an independent risk factor for OS, suggesting need for better chemo regimens and GvHD management.

© Copyright 2025. All Rights Reserved by MedPath